Kesimpta (Ofatumumab) Pregnancy Registry — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Kesimpta (Ofatumumab) Pregnancy Registry — Stella

Recruiting

Back to Multiple Sclerosis trials

Trial locations(1 site)

United States

University of California San Diego OTIS, La Jolla, California

Key details

Sponsor

Novartis Pharmaceuticals

Enrollment target

~725 participants

Started

January 2023

Primary completion

February 2033

Age range

18 Years – 100 Years

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov